Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):421–428. doi: 10.1097/QAI.0000000000001686

Table 3.

Multivariable Models Relating Sex to Presence of Plaque and Presence of Positively Remodeled Plaque Among ART-Treated HIV-Infected Women and Men (n = 142)

Presence of Any Plaque Presence of Positively Remodeled Plaque
Odds Ratio [95% CI] P-value Odds Ratio [95% CI] P-value
Age, y 6.6 [3.0, 16.0] < 0.0001 3.4 [1.7, 7.2] 0.0007
Male sex 3.8 [1.4, 11.4] 0.01 3.7 [1.4, 10.9] 0.01
White race 5.2 [0.8, 49.7] 0.11 2.8 [0.5, 24.4] 0.29
Black/African American race 5.2 [0.8, 48.0] 0.10 2.2 [0.4, 18.4] 0.41
Hispanic race/ethnicity 0.7 [0.07, 9.0] 0.81 0.5 [0.04, 5.6] 0.54
Current hypertension 1.6 [0.6, 5.0] 0.38 1.4 [0.6, 3.8] 0.45
Current diabetes mellitus 0.8 [0.2, 2.9] 0.71 0.7 [0.2, 2.5] 0.63
HDL-C, mg/dL 0.9 [0.7, 1.1] 0.28 1.0 [0.8, 1.3] 0.97
VAT, cm2 1.0 [0.9, 1.0] 0.30 1.0 [0.9, 1.0] 0.18
NRTI use 1.2 [0.1, 9.9] 0.88 1.4 [0.2, 12.5] 0.77
NNRTI use 1.1 [0.4, 3.6] 0.82 1.0 [0.3, 3.1] 0.99
PI use 0.6 [0.2, 1.8] 0.36 0.8 [0.3, 2.2] 0.64

Odds ratios and P-values were determined by multivariable logistic regression. Odds ratios for continuous variables are reported per a 10-unit change in the variable of interest. Odds ratios for categorical variables compare odds of presence versus absence of parameter.

HDL-C, high-density lipoprotein cholesterol; NNRTIs, non-nucleoside reverse transcriptase inhibitors; NRTIs, nucleoside reverse transcriptase inhibitors; PIs, protease inhibitors; VAT, visceral adipose tissue.